NoDownsideToOutside
NoDownsideToOutside t1_ixw1ihm wrote
Reply to comment by ComradeBlyat308 in A novel medication for hemophilia B has just been approved by the Food and Drug Administration. The treatment is a form of gene therapy, intended to replace a dysfunctional gene that leaves people unable to control their bleeding. by Sariel007
People fail to realize the grants these labs are given. These companies are definitely double dipping. I’m not saying stuff like this isn’t hard to produce, but I doubt $3.5 mil/dose worth of labor, and research was done, even without grants/subsidies/tax breaks the company received.
Also a lot of these things are developed and then the company buys the patents solely for distribution profits.
NoDownsideToOutside t1_ivguyuq wrote
Reply to comment by Urag-gro_Shub in English company Oxitec has released a simple, easy to distribute commercial product they say cuts Dengue Fever spreading mosquito populations by 96%. By just adding water, genetically modified mosquito eggs mature into males whose sperm cannot result in viable female larvae. by lughnasadh
There’s only one type of mosquito known to transmit deadly diseases out of the 200+ different mosquitoes.
Ridding the world of this one would prevent millions of deaths and mental disabilities that come about through this mosquito. No scientific paper has come to the conclusion that getting rid of it would have any noticeable effect on the environment since other species would take its place.
NoDownsideToOutside t1_j6glgox wrote
Reply to comment by DixenSyder in Scientists lower price of lithium's best competition - flow batteries - by 20%. Makes the battery effectively equal to or cheaper than lithium ion when spread over 30 years (flow battery lifetimes are effectively infinite with light repowering efforts). by PorkyPigDid911
The metals in lithium ion are infinitely recyclable and easier and more cost effective to do so.
Not like plastic where you can recycle it, but it’s expensive and a pain in the ass